These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 10846827)

  • 1. Sensitivity of human melanoma cells to adherent leukocytes depends on the ratio between them, the activation status of adherent leukocytes and the metastatic potential of tumor cells.
    Thomas C; Fertil B
    Cancer Immunol Immunother; 2001 Jun; 50(4):181-90. PubMed ID: 11459170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.
    Steck TL; Kant JA
    Methods Enzymol; 1974; 31():172-80. PubMed ID: 4370662
    [No Abstract]   [Full Text] [Related]  

  • 3. Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis.
    De Palma A; Roveri A; Zaccarin M; Benazzi L; Daminelli S; Pantano G; Buttarello M; Ursini F; Gion M; Mauri PL
    J Chromatogr A; 2010 Aug; 1217(33):5328-36. PubMed ID: 20621298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of human erythrocyte ghosts in isotonic solution: haemoglobin content and polypeptide composition.
    Saleemuddin M; Zimmermann U; Schneeweiss F
    Z Naturforsch C Biosci; 1977; 32(7-8):627-31. PubMed ID: 143824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double in vivo Biotinylation Technique for Objective Assessment of Aging and Clearance of Mouse Erythrocytes in Blood Circulation.
    Saxena RK; Bhardwaj N; Sachar S; Puri N; Khandelwal S
    Transfus Med Hemother; 2012 Oct; 39(5):335-41. PubMed ID: 23801925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should erythrocyte destruction in vivo be through phagocytosis alone?
    Saxena RK
    J Biosci; 2000 Mar; 25(1):3-5. PubMed ID: 10824189
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the spleen in erythrocyte destruction].
    Hromec A; Jakubovský J
    Cesk Fysiol; 1983; 32(5):438-42. PubMed ID: 6357499
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the tumor necrosis factor-alpha-mediated lysis by fixed natural cytotoxic cells and fixed cytotoxic macrophages.
    Vanderslice WE; Collins JL
    J Immunol; 1991 Jan; 146(1):156-61. PubMed ID: 1984442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro erythrocidal activity of activated spleen cells from young and old mice.
    Saxena RK; Adler WH
    Exp Gerontol; 2000 May; 35(3):409-16. PubMed ID: 10832060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Trypanosoma congolense and Trypanosoma vivax.
    Taiwo VO; Anosa VO
    Onderstepoort J Vet Res; 2000 Dec; 67(4):273-87. PubMed ID: 11206395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonphagocytic mechanism of erythrocyte destruction involving direct cell-mediated cytotoxicity.
    Saxena RK; Chandrasekhar B
    Int J Hematol; 2000 Apr; 71(3):227-37. PubMed ID: 10846827
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.